Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New shot could stop Cold-Triggered hives in their tracks
Symptom relief CompletedThis study tested a new drug called barzolvolimab (CDX-0159) in 196 adults with chronic inducible urticaria—hives caused by cold or scratching—that antihistamines couldn't control. Participants received either the drug or a placebo to see if it could stop wheals and reduce itchin…
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated May 17, 2026 06:19 UTC
-
New drug shows promise for swallowing trouble in eosinophilic esophagitis
Symptom relief CompletedThis study tested a drug called barzolvolimab in 86 adults with active eosinophilic esophagitis, a condition that causes swallowing problems due to inflammation in the esophagus. Participants received either the drug or a placebo to see if it could reduce symptoms and signs of in…
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New drug CDX-622 put to the test in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called CDX-622 in 85 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side effects, drug levels in the blood, and changes in certain body chemicals. The goal was …
Phase: PHASE1 • Sponsor: Celldex Therapeutics • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC